PMC:7696151 / 85506-85660 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"2536","span":{"begin":130,"end":138},"obj":"Species"},{"id":"2550","span":{"begin":65,"end":77},"obj":"Chemical"},{"id":"2551","span":{"begin":102,"end":105},"obj":"Chemical"},{"id":"2571","span":{"begin":12,"end":20},"obj":"Disease"}],"attributes":[{"id":"A2536","pred":"tao:has_database_id","subj":"2536","obj":"Tax:9606"},{"id":"A2550","pred":"tao:has_database_id","subj":"2550","obj":"MESH:D000077204"},{"id":"A2551","pred":"tao:has_database_id","subj":"2551","obj":"MESH:D006886"},{"id":"A2571","pred":"tao:has_database_id","subj":"2571","obj":"MESH:D008545"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" metastatic melanoma, by administering a dose intense regimen of temozolomide and escalating doses of HCQ (200–1200 mg/day p.o.). Patients well tolerated "}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T212","span":{"begin":12,"end":20},"obj":"Phenotype"}],"attributes":[{"id":"A212","pred":"hp_id","subj":"T212","obj":"http://purl.obolibrary.org/obo/HP_0002861"}],"text":" metastatic melanoma, by administering a dose intense regimen of temozolomide and escalating doses of HCQ (200–1200 mg/day p.o.). Patients well tolerated "}